Pasithea Therapeutics Corp.
KTTAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001841330
No open-market purchases or sales by Pasithea Therapeutics Corp. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $3.18K in total; no superinvestor holds it.
Other share classesKTTA
Superinvestors holding KTTAW, Q2 2026
No superinvestor reported holding KTTAW in Q2 2026.